2022
DOI: 10.7759/cureus.24354
|View full text |Cite
|
Sign up to set email alerts
|

Rare Coronary Embolism Secondary to Cardioversion of Atrial Fibrillation

Abstract: The diagnosis and management of myocardial infarction with nonobstructive coronary arteries (MINOCA) are difficult due to its variable presentations, different causes, and challenging diagnostic approaches. Cardiac imaging modalities including cardiac magnetic resonance (CMR) are very useful tools for diagnosing and managing MINOCA. Myocardial infarction (MI) can be caused by coronary emboli that can be contributed to atrial fibrillation (AF). Rarely, coronary embolism with resultant MINOCA can occur after dir… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…7 In patients with multiple risk factors for HF, CMR has the potential to differentiate anthracycline-induced cardiomyopathy from other non-ischemic causes of HF, such as AF, and may play an essential role in guiding HF management and improving patient outcomes. 8,9 Recent studies have explored the prognostic value of CMR in predicting LVEF improvement following AF ablation in patients with non-ischemic heart failure with reduced ejection fraction (HFrEF). 5,10 The absence of LV fibrosis, as detected by LGE and T1 extracellular volume fraction mapping, has been shown to correlate with greater improvement in LV systolic function following AF ablation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…7 In patients with multiple risk factors for HF, CMR has the potential to differentiate anthracycline-induced cardiomyopathy from other non-ischemic causes of HF, such as AF, and may play an essential role in guiding HF management and improving patient outcomes. 8,9 Recent studies have explored the prognostic value of CMR in predicting LVEF improvement following AF ablation in patients with non-ischemic heart failure with reduced ejection fraction (HFrEF). 5,10 The absence of LV fibrosis, as detected by LGE and T1 extracellular volume fraction mapping, has been shown to correlate with greater improvement in LV systolic function following AF ablation.…”
Section: Discussionmentioning
confidence: 99%
“… 7 In patients with multiple risk factors for HF, CMR has the potential to differentiate anthracycline-induced cardiomyopathy from other non-ischemic causes of HF, such as AF, and may play an essential role in guiding HF management and improving patient outcomes. 8 , 9 …”
Section: Discussionmentioning
confidence: 99%